Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Loading
Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Calendar quarter Q2 2026Earnings call Aug 4, 2026 · most recent call
IDXX’s newest analyzed quarter is part of Tellvest Pro: its score, breakdown, narrative and analyst Q&A. Every prior quarter is free.
Sources. Scores: Idexx Laboratories’s public earnings-call transcripts and SEC-reported results — the base band is anchored to reported GAAP revenue growth; transcript, EPS and guidance adjustments are applied separately (documented exceptions apply to a few issuers). Price: IDXX daily closing prices for the trailing year; dots mark earnings calls, colored by that quarter’s score; the newest quarter’s score is part of Tellvest Pro. How to read a company earnings-call score.
All prior quarters are free. How to browse earnings-call scores without Pro. How to read a company earnings-call score.
The breakdown for this quarter is part of Tellvest Pro.
Full Pro access for 30 days when you create a free account. No credit card required.
No 8-K events recorded since this call day.
The table scrolls sideways. Swipe it, or select it and use the arrow keys.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Gross margin | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $954M | +5.8% | $2.62 | +12.9% | 59.8% | 27.4% | 22.7% | $223M |
| FY2025 Q1 | $998M | +3.6% | $2.96 | +5.3% | 62.4% | 31.7% | 24.3% | $208M |
| FY2025 Q2 | $1.11B | +10.6% | $3.63 | +48.8% | 62.6% | 33.6% | 26.5% | $152M |
| FY2025 Q3 | $1.11B | +13.3% | $3.40 | +21.4% | 61.8% | 32.1% | 24.8% | $371M |
| FY2025 Q4 | $1.09B | +14.3% | $3.08 | +17.6% | 60.3% | 28.9% | 22.8% | $323M |
| FY2026 Q1 | $1.14B | +14.3% | $3.47 | +17.2% | 63.4% | 31.8% | 24.4% | $234M |
| FY2026 Q2Selected | $1.22B | +9.7% | $4.27 | +17.6% | 64.0% | 35.0% | 27.8% | $323M |
Management-stated figures from IDXX’s newest call are part of Tellvest Pro.